Free Trial

K Charles Janac Sells 11,815 Shares of Arteris, Inc. (NASDAQ:AIP) Stock

Arteris logo with Computer and Technology background

Arteris, Inc. (NASDAQ:AIP - Get Free Report) CEO K Charles Janac sold 11,815 shares of the firm's stock in a transaction that occurred on Thursday, July 3rd. The stock was sold at an average price of $9.25, for a total value of $109,288.75. Following the completion of the sale, the chief executive officer owned 284,030 shares of the company's stock, valued at $2,627,277.50. This represents a 3.99% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link.

K Charles Janac also recently made the following trade(s):

  • On Wednesday, July 2nd, K Charles Janac sold 7,153 shares of Arteris stock. The stock was sold at an average price of $8.99, for a total value of $64,305.47.
  • On Tuesday, July 1st, K Charles Janac sold 2,666 shares of Arteris stock. The stock was sold at an average price of $9.09, for a total value of $24,233.94.
  • On Friday, June 27th, K Charles Janac sold 18,620 shares of Arteris stock. The stock was sold at an average price of $10.02, for a total value of $186,572.40.
  • On Wednesday, June 4th, K Charles Janac sold 2,057 shares of Arteris stock. The stock was sold at an average price of $7.83, for a total value of $16,106.31.
  • On Monday, June 2nd, K Charles Janac sold 1,246 shares of Arteris stock. The stock was sold at an average price of $7.70, for a total value of $9,594.20.

Arteris Stock Down 2.2%

AIP traded down $0.21 during trading on Thursday, hitting $9.22. The company's stock had a trading volume of 393,434 shares, compared to its average volume of 232,246. The firm's 50 day moving average price is $8.11 and its two-hundred day moving average price is $8.57. Arteris, Inc. has a 12 month low of $5.46 and a 12 month high of $12.64. The stock has a market capitalization of $387.06 million, a price-to-earnings ratio of -11.24 and a beta of 1.44.

Hedge Funds Weigh In On Arteris

Several institutional investors have recently bought and sold shares of the business. G2 Investment Partners Management LLC acquired a new stake in shares of Arteris in the 4th quarter valued at $2,799,000. Charles Schwab Investment Management Inc. increased its stake in shares of Arteris by 4.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 78,690 shares of the company's stock valued at $802,000 after buying an additional 3,298 shares during the period. BNP Paribas Financial Markets acquired a new stake in shares of Arteris in the 4th quarter valued at $214,000. Two Sigma Advisers LP grew its stake in shares of Arteris by 82.9% during the fourth quarter. Two Sigma Advisers LP now owns 23,600 shares of the company's stock worth $240,000 after purchasing an additional 10,700 shares during the period. Finally, EAM Investors LLC acquired a new stake in shares of Arteris during the fourth quarter worth $983,000. Institutional investors own 64.36% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Rosenblatt Securities restated a "buy" rating and set a $14.00 target price on shares of Arteris in a research report on Wednesday, May 21st.

Check Out Our Latest Stock Report on Arteris

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

See Also

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines